Mitotoxicity in Distal Symmetrical Sensory Peripheral Neuropathies

Overview

Journal Nat Rev Neurol

Specialty Neurology

Date 2014 May 21

PMID 24840972

Citations 99

Authors

Gary J Bennett

Timothy Doyle

Daniela Salvemini

Affiliations

Soon will be listed here.

Abstract

Chronic distal symmetrical sensory peripheral neuropathy is a common neurological complication of cancer chemotherapy, HIV treatment and diabetes. Although aetiology-specific differences in presentation are evident, the clinical signs and symptoms of these neuropathies are clearly similar. Data from animal models of neuropathic pain suggest that the similarities have a common cause: mitochondrial dysfunction in primary afferent sensory neurons. Mitochondrial dysfunction is caused by mitotoxic effects of cancer chemotherapeutic drugs of several chemical classes, HIV-associated viral proteins, and nucleoside reverse transcriptase inhibitor treatment, as well as the (possibly both direct and indirect) effects of excess glucose. The mitochondrial injury results in a chronic neuronal energy deficit, which gives rise to spontaneous nerve impulses and a compartmental neuronal degeneration that is first apparent in the terminal receptor arbor--that is, intraepidermal nerve fibres--of cutaneous afferent neurons. Preliminary data suggest that drugs that prevent mitochondrial injury or improve mitochondrial function could be useful in the treatment of these conditions.

Citing Articles

Mitochondrial A Adenosine Receptor as a Mechanism for the Protective Effects of AAR Agonists on Chemotherapy-Induced Neuropathic Pain.

Doyle T, Janes K, Xiao W, Kolar G, Kolar G, Luecke H J Neurosci. 2024; 45(3.

PMID: 39653498 PMC: 11735668. DOI: 10.1523/JNEUROSCI.1268-24.2024.

Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways.

Bourke S, Suarez E, Islam B, Stephenson J, Finn D, McHugh P Eur J Clin Invest. 2024; 55(2):e14351.

PMID: 39545479 PMC: 11744925. DOI: 10.1111/eci.14351.

Proteomic analysis of dorsal root ganglia in a mouse model of paclitaxel-induced neuropathic pain.

Hanna R, Graur A, Sinclair P, Mckiver B, Bos P, Damaj M PLoS One. 2024; 19(9):e0306498.

PMID: 39331687 PMC: 11432834. DOI: 10.1371/journal.pone.0306498.

Targeting metabolic pathways alleviates bortezomib-induced neuropathic pain without compromising anticancer efficacy in a sex-specific manner.

Kuppusamy P, Haque M, Traub R, Melemedjian O Front Pain Res (Lausanne). 2024; 5:1424348.

PMID: 38979441 PMC: 11228363. DOI: 10.3389/fpain.2024.1424348.

Proteomic Analysis of Dorsal Root Ganglia in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.

Hanna R, Graur A, Sinclair P, Mckiver B, Paula D Bos M, Damaj M bioRxiv. 2024; .

PMID: 38979383 PMC: 11230256. DOI: 10.1101/2024.06.20.599888.

References

Loprinzi C, Maddocks-Christianson K, Wolf S, Rao R, Dyck P, Mantyh P . The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J. 2007; 13(6):399-403. DOI: 10.1097/PPO.0b013e31815a999b. View

Xiao W, Bennett G . Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine. Pain. 2007; 135(3):262-270. PMC: 2689385. DOI: 10.1016/j.pain.2007.06.001. View

Cascinu S, Catalano V, Cordella L, Labianca R, Giordani P, Baldelli A . Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2002; 20(16):3478-83. DOI: 10.1200/JCO.2002.07.061. View

Saleh A, Roy Chowdhury S, Smith D, Balakrishnan S, Tessler L, Martens C . Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents. Neuropharmacology. 2012; 65:65-73. PMC: 3521091. DOI: 10.1016/j.neuropharm.2012.09.015. View

Sivitz W, Yorek M . Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal. 2009; 12(4):537-77. PMC: 2824521. DOI: 10.1089/ars.2009.2531. View

Herzberg U, Sagen J . Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol. 2001; 116(1):29-39. DOI: 10.1016/s0165-5728(01)00288-0. View

Herrmann D, Griffin J, Hauer P, Cornblath D, McArthur J . Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology. 1999; 53(8):1634-40. DOI: 10.1212/wnl.53.8.1634. View

Tomlinson D, Gardiner N . Glucose neurotoxicity. Nat Rev Neurosci. 2007; 9(1):36-45. DOI: 10.1038/nrn2294. View

Fernyhough P, Roy Chowdhury S, Schmidt R . Mitochondrial stress and the pathogenesis of diabetic neuropathy. Expert Rev Endocrinol Metab. 2010; 5(1):39-49. PMC: 2924887. DOI: 10.1586/eem.09.55. View

10.

Norman J, Perry S, Reynolds H, Kiebala M, Bentley K, Trejo M . HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One. 2008; 3(11):e3731. PMC: 2579580. DOI: 10.1371/journal.pone.0003731. View

11.

Papanas N, Vinik A, Ziegler D . Neuropathy in prediabetes: does the clock start ticking early?. Nat Rev Endocrinol. 2011; 7(11):682-90. DOI: 10.1038/nrendo.2011.113. View

12.

Vincent A, Edwards J, McLean L, Hong Y, Cerri F, Lopez I . Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol. 2010; 120(4):477-89. PMC: 4254759. DOI: 10.1007/s00401-010-0697-7. View

13.

Lehmann H, Chen W, Borzan J, Mankowski J, Hoke A . Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann Neurol. 2011; 69(1):100-10. PMC: 3051401. DOI: 10.1002/ana.22150. View

14.

Drose S, Brandt U . Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol. 2012; 748:145-69. DOI: 10.1007/978-1-4614-3573-0_6. View

15.

Rausaria S, Ghaffari M, Kamadulski A, Rodgers K, Bryant L, Chen Z . Retooling manganese(III) porphyrin-based peroxynitrite decomposition catalysts for selectivity and oral activity: a potential new strategy for treating chronic pain. J Med Chem. 2011; 54(24):8658-69. PMC: 3240686. DOI: 10.1021/jm201233r. View

16.

Lin P, Lee M, Wang W, Yen C, Chao T, Hsiao L . N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Support Care Cancer. 2006; 14(5):484-7. DOI: 10.1007/s00520-006-0018-9. View

17.

Latremoliere A, Woolf C . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9):895-926. PMC: 2750819. DOI: 10.1016/j.jpain.2009.06.012. View

18.

Doyle T, Chen Z, Muscoli C, Bryant L, Esposito E, Cuzzocrea S . Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J Neurosci. 2012; 32(18):6149-60. PMC: 3752044. DOI: 10.1523/JNEUROSCI.6343-11.2012. View

19.

Jin H, Flatters S, Xiao W, Mulhern H, Bennett G . Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol. 2007; 210(1):229-37. PMC: 2323600. DOI: 10.1016/j.expneurol.2007.11.001. View

20.

Zheng H, Xiao W, Bennett G . Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol. 2011; 232(2):154-61. PMC: 3202047. DOI: 10.1016/j.expneurol.2011.08.016. View